v3.26.1
Equity Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2025
Equity Compensation Plans [Abstract]  
Schedule of Stock Option Activity

The following table summarizes the Company’s total stock option activity for the years ended December 31, 2025 and 2024:

 

   Options
(in thousands)
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term in
Years
   Intrinsic
Value $
(in thousands)
 
Options outstanding as of December 31, 2023   863   $8.13    2.2   $
 
Granted   
    
        
 
Forfeited   
    
        
 
Expired   (334)   9.67        
 
Options outstanding as of December 31, 2024   529   $7.17    2.2   $
 
Granted   
    
        
 
Forfeited   
    
        
 
Expired   (29)   13.12        
 
Options outstanding as of December 31, 2025   500   $6.82    1.3   $
 
Schedule of Outstanding and Exercisable Stock Options

Outstanding and exercisable stock options as of December 31, 2025 are as follows:

 

      Options Outstanding     Options Exercisable  
Exercise Prices     Number of
Options
Outstanding
(in thousands)
    Weighted
Average
Remaining Life
(Years)
    Number of
Options
Exercisable
(in thousands)
    Weighted
Average
Remaining Life
(Years)
    Intrinsic
Value
(in thousands)
 
$ 6.82       500     1.3       500     1.3     $     —  
Schedule of Restricted Stock Unit Activity and Stock Option Activity

The following table summarizes the Company’s unvested stock option activity for the years ended December 31, 2025 and 2024:

 

   Options
(in thousands)
   Weighted
Average
Grant Date
Fair Value
 
Nonvested options as of December 31, 2023   337   $0.41 
Granted   
    
 
Vested   (170)   0.59 
Forfeited   
    
 
Nonvested options as of December 31, 2024   167   $0.22 
Granted   
    
 
Vested   (167)   0.22 
Forfeited   
     
Nonvested options as of December 31, 2025   
    
 

The following table summarizes the Company’s restricted stock unit activity for the years ended December 31, 2025 and 2024:

 

   Units
(in thousands)
   Weighted
Average
Grant Date
Fair Value
 
Nonvested restricted stock units as of December 31, 2023   3,057   $2.97 
Granted   1,828    1.03 
Vested   (571)   3.57 
Forfeited   (506)   3.31 
Nonvested restricted stock units as of December 31, 2024   3,808   $1.91 
Granted   1,150    0.66 
Vested   (919)   2.22 
Forfeited   (898)   2.30 
Nonvested restricted stock units as of December 31, 2025   3,141    1.25 
Schedule of Weighted Average Grant Date Fair Value The Company determined the weighted average grant date fair value of these awards using a Monte Carlo Simulation of a Geometric Brownian Motion stock path model with the following weighted average assumptions:
   Year Ended
December 31,
2024
 
Trading price of common stock on measurement date  $1.50 
Risk free interest rate   4.46%
Expected life in years   3.0 
Expected volatility   97.1%
Expected dividend yield   
 
Schedule of Non-Cash Stock-Based Compensation Recognized in the Statement of Operations The table below summarizes the aggregate non-cash stock compensation recognized in the statement of operations for stock awards, employee stock options and employee restricted stock units (in thousands).
   Years Ended December 31, 
   2025   2024   2023 
Cost of revenues  $355   $398   $285 
Marketing and sales   21    489    616 
General and administrative   1,104    1,621    3,730 
Research and development   249    307    244 
Total non-cash stock compensation  $1,729   $2,815   $4,875